Partner

Articles & Insights / Analytical Preparation

Sample Preparation Is Part of the Analytical Method

A chromatographic system can be precise while the reported result is wrong. If extraction, dilution or filtration changes the amount of analyte reaching the instrument, repeated injections simply reproduce the same preparation bias.

Stabicon Life Sciences3 min read

Accreditations, approvals & registrations

  • Prequalified by WHO, Geneva

    One of the Only 6 Commercial Testing Facilities in India to have a WHO Geneva Approval

  • Accredited by ISO/IEC 17025:2017 (NABL)

  • Approved by FSSAI

  • Approved by CDSCO, India

  • Facility Registered with FDA, Karnataka

  • Registered with DSIR

  • Registered with AYUSH

All articles

What this article helps you consider

  • Define what the preparation must recover
  • Select the solvent system using the actual matrix
  • Separate extraction loss from chemical change

Define what the preparation must recover

Identify the analyte, matrix and the material basis of the reportable result. An assay of a crushed tablet composite differs from a determination of individual-unit content. A trace impurity procedure may need to preserve a labile analyte at concentrations where adsorption becomes significant.

ICH Q14 and Q2(R2) support developing and demonstrating analytical performance for the intended use. Sample preparation belongs within that evidence because it forms part of the route from product to reportable result. Instrument capability alone cannot establish complete-method suitability. R05R04

Select the solvent system using the actual matrix

The analyte must be sufficiently soluble, but the formulation also affects extraction. Polymers can swell, coatings can resist penetration and oils can partition differently. A clear supernatant is not proof that extraction is complete, and a turbid preparation is not necessarily unsuitable if the procedure controls its consequences appropriately.

Investigate solvent composition, order of addition, mixing and extraction duration. Increasing solvent strength can improve recovery while extracting more interference. Increasing sonication time can introduce heat or accelerate degradation. Select conditions that balance recovery, stability and analytical selectivity.

Separate extraction loss from chemical change

A low result can reflect incomplete recovery, precipitation, adsorption or degradation. Design experiments that distinguish these mechanisms. Sequential extraction may reveal analyte remaining in the residue, while preparation-time studies can show whether the analyte declines after initial recovery.

The illustration shows invented recovery-versus-time profiles. One reaches a plateau, while another declines after an initial maximum. The illustration explains why longer extraction is not automatically better. Actual conclusions require controls capable of showing whether the measured change is extraction, degradation or another effect.

Explore the scienceAnalytical Preparation
Measured recovery (%)6575.7586.597.25108510153045 Hypothetical stable preparation: 5, 78Hypothetical stable preparation: 10, 94Hypothetical stable preparation: 15, 99Hypothetical stable preparation: 30, 100Hypothetical stable preparation: 45, 100 Hypothetical unstable preparation: 5, 78Hypothetical unstable preparation: 10, 96Hypothetical unstable preparation: 15, 99Hypothetical unstable preparation: 30, 91Hypothetical unstable preparation: 45, 80Extraction time (minutes)

Invented recovery data. Mechanisms require suitable controls; no universal extraction time or acceptance range is established.

Invented extraction profiles illustrate a plateau and a later decline in measured recovery. Distinguishing extraction, degradation and other mechanisms requires suitable experimental controls.

Evaluate filtration and transfer

Membrane chemistry, pore size, sample concentration and discarded volume can affect adsorption or extractable interference. Compare candidate filters with a justified reference preparation and evaluate relevant concentrations. A filter that is acceptable for a high-level assay may be unsuitable for a trace impurity in the same formulation.

Consider vials, closures, pipette tips and transfer surfaces where adsorption or contamination is plausible. Internal standards can compensate for some variation only when added at the right stage and when their behaviour sufficiently represents the target analyte. Adding one after extraction cannot reveal an extraction loss that has already occurred.

Design recovery experiments that answer the question

A spike added to a finished extract mainly assesses the measurement stage. A spike introduced before extraction provides different information, but may not perfectly mimic an analyte embedded in the manufactured matrix. Use suitable combinations of recovery experiments, reference materials and product comparisons.

For a hypothetical botanical tablet, good recovery of a dissolved marker spike does not prove that native marker is fully released from the plant particles. Investigate that distinction before concluding that the procedure measures the total marker content. Document limitations where a complete reference recovery cannot be established.

Make the procedure reproducible

Specify meaningful preparation details, including sample size, solvent volumes, extraction conditions, temperature limits, filtration and permitted holding time. Define how homogeneity is maintained and when a preparation must be repeated. Avoid relying on an analyst’s undocumented judgement of what sufficiently mixed looks like.

Stabicon can develop preparation procedures alongside separation and detection methods, so that accuracy and precision reflect the complete analysis. A well-understood preparation also makes validation and transfer between laboratories more reliable.

References & further reading

Read the source in its stated scope. Requirements, amendments and compendial editions depend on the product and target market. Draft guidance is identified separately.

  1. R04
    ICH Q2 R2 Validation of Analytical Procedures

    Final guideline adopted November 2023. Analytical validation framework.

  2. R05
    ICH Q14 Analytical Procedure Development

    Final guideline adopted November 2023. Development and lifecycle approaches.

From insight to a defined programme

Bring your next technical question.

Share your formulation, testing objective or development challenge. Stabicon can review the context and define a suitable scope of work.

Discuss this topic with Stabicon

Continue reading

Related scientific perspectives.

Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Request a consent withdrawal at bd@stabicon.com.

Press Kit

Logos, company information & spokesperson details – available from our media team.

Request Press Kit

Accreditations

Prequalified by WHO, GenevaAccredited by ISO/IEC 17025:2017 (NABL)Approved by FSSAIApproved by CDSCO, IndiaFacility Registered with FDA, KarnatakaRegistered with DSIRRegistered with AYUSHOne of the Only 6 Commercial Testing Facilities in India to have a WHO Geneva Approval

Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Product packaging and materials may vary from those shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.

Admin